Drug Type Oligonucleotide |
Synonyms- |
Target |
Action inhibitors |
Mechanism TDP43 inhibitors(TAR DNA binding protein 43 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Discovery | United States | 22 Mar 2024 |





